Guimond MO - Search Results

1

High affinity rigidified AT₂ receptor ligands with indane scaffolds.

Wallinder C, Sköld C, Sundholm S, Guimond MO, Yahiaoui S, Lindeberg G, Gallo-Payet N, Hallberg M, Alterman M. Wallinder C, et al. Among authors: guimond mo. Medchemcomm. 2019 Nov 18;10(12):2146-2160. doi: 10.1039/c9md00402e. eCollection 2019 Dec 1. Medchemcomm. 2019. PMID: 32904210 Free PMC article.

2

Interconversion of Functional Activity by Minor Structural Alterations in Nonpeptide AT2 Receptor Ligands.

Wallinder C, Sköld C, Botros M, Guimond MO, Hallberg M, Gallo-Payet N, Karlén A, Alterman M. Wallinder C, et al. Among authors: guimond mo. ACS Med Chem Lett. 2014 Dec 8;6(2):178-82. doi: 10.1021/ml500427r. eCollection 2015 Feb 12. ACS Med Chem Lett. 2014. PMID: 25699147 Free PMC article.

3

Selective angiotensin II AT2 receptor agonists: Benzamide structure-activity relationships.

Wallinder C, Botros M, Rosenström U, Guimond MO, Beaudry H, Nyberg F, Gallo-Payet N, Hallberg A, Alterman M. Wallinder C, et al. Among authors: guimond mo. Bioorg Med Chem. 2008 Jul 15;16(14):6841-9. doi: 10.1016/j.bmc.2008.05.066. Epub 2008 Jul 1. Bioorg Med Chem. 2008. PMID: 18599297

4

From the first selective non-peptide AT(2) receptor agonist to structurally related antagonists.

Murugaiah AM, Wu X, Wallinder C, Mahalingam AK, Wan Y, Sköld C, Botros M, Guimond MO, Joshi A, Nyberg F, Gallo-Payet N, Hallberg A, Alterman M. Murugaiah AM, et al. Among authors: guimond mo. J Med Chem. 2012 Mar 8;55(5):2265-78. doi: 10.1021/jm2015099. Epub 2012 Feb 22. J Med Chem. 2012. PMID: 22248302

5

Comparative functional properties of two structurally similar selective nonpeptide drug-like ligands for the angiotensin II type-2 (AT(2)) receptor. Effects on neurite outgrowth in NG108-15 cells.

Guimond MO, Wallinder C, Alterman M, Hallberg A, Gallo-Payet N. Guimond MO, et al. Eur J Pharmacol. 2013 Jan 15;699(1-3):160-71. doi: 10.1016/j.ejphar.2012.11.032. Epub 2012 Dec 2. Eur J Pharmacol. 2013. PMID: 23211679

6

N-Aryl Isoleucine Derivatives as Angiotensin II AT2 Receptor Ligands.

Behrends M, Wallinder C, Wieckowska A, Guimond MO, Hallberg A, Gallo-Payet N, Larhed M. Behrends M, et al. Among authors: guimond mo. ChemistryOpen. 2014 Apr;3(2):65-75. doi: 10.1002/open.201300040. Epub 2014 Mar 13. ChemistryOpen. 2014. PMID: 24808993 Free PMC article.

7

Saralasin and Sarile Are AT2 Receptor Agonists.

Guimond MO, Hallberg M, Gallo-Payet N, Wallinder C. Guimond MO, et al. ACS Med Chem Lett. 2014 Aug 18;5(10):1129-32. doi: 10.1021/ml500278g. eCollection 2014 Oct 9. ACS Med Chem Lett. 2014. PMID: 25313325 Free PMC article.

8

The Angiotensin II Type 2 Receptor in Brain Functions: An Update.

Guimond MO, Gallo-Payet N. Guimond MO, et al. Int J Hypertens. 2012;2012:351758. doi: 10.1155/2012/351758. Epub 2012 Dec 25. Int J Hypertens. 2012. PMID: 23320146 Free PMC article.

9

Involvement of protein kinase C alpha (PKC alpha) in the early action of angiotensin II type 2 (AT2) effects on neurite outgrowth in NG108-15 cells: AT2-receptor inhibits PKC alpha and p21ras activity.

Beaudry H, Gendron L, Guimond MO, Payet MD, Gallo-Payet N. Beaudry H, et al. Among authors: guimond mo. Endocrinology. 2006 Sep;147(9):4263-72. doi: 10.1210/en.2006-0411. Epub 2006 Jun 1. Endocrinology. 2006. PMID: 16740968

10

Role of tyrosine kinase receptors in angiotensin II AT2 receptor signaling: involvement in neurite outgrowth and in p42/p44mapk activation in NG108-15 cells.

Plouffe B, Guimond MO, Beaudry H, Gallo-Payet N. Plouffe B, et al. Among authors: guimond mo. Endocrinology. 2006 Oct;147(10):4646-54. doi: 10.1210/en.2005-1315. Epub 2006 Jun 29. Endocrinology. 2006. PMID: 16809450

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

21 results

Search Page